The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Terpenes on the Frontline: Potential Benefits in Breast Cancer
|
|
Author(s): Minky Mukhija (Ch. Devi Lal College of Pharmacy, Jagadhri, India), Sonia Kamboj (Ch. Devi Lal College of Pharmacy, Jagadhri, India), Jyoti Monga (Ch. Devi Lal College of Pharmacy, Jagadhri, India), Devkant Sharma (Ch. Devi Lal College of Pharmacy, Jagadhri, India)and Anurag Bhargava (Ch. Devi Lal College of Pharmacy, Jagadhri, India)
Copyright: 2025
Pages: 30
Source title:
Analyzing Terpenes' Role in Cancer Treatment
Source Author(s)/Editor(s): Bhawna Chopra (Guru Gobind Singh College of Pharmacy, India), Ashwani Kumar Dhingra (Global Research Institute of Pharmacy, India), Priyanka Kriplani (Guru Gobind Singh College of Pharmacy, India)and Ritu Ojha (Cathay General Hospital, Taiwan)
DOI: 10.4018/979-8-3693-6972-2.ch011
Purchase
|
Abstract
Breast cancer is the common invasive cancer in women, affecting around 12% of all women globally. Many effective anticancer medications with different chemical structures have been developed to treat breast cancer. However, patients have severe adverse effects from their non selectivity. Terpenes are a broad and diversified class of naturally occurring substances. They are made by combining several isoprene units, which are five-carbon bases. Terpenoids are typically categorised as monoterpenes, sesquiterpenes, diterpenes, sesterterpenes, triterpenes, tetraterpenes and polyterpenes based on the number of building units. This class of phytochemicals include a number of possible anti-breast cancer medicines. Natural terpenoids have given rise to paclitaxel, one of the most effective therapeutic medications for treating metastatic breast cancer. With the passage of time, other well-known terpenoids have emerged as essential components of contemporary breast cancer pharmacotherapy. The potential of terpenoids as anticancer medicines against breast cancer will be discussed in this chapter
Related Content
|
Yiannis Koumpouros.
© 2026.
36 pages.
|
|
Antonios Archontis, Yiannis Koumpouros.
© 2026.
48 pages.
|
|
R Velmurugan, J Sudarvel, Ravi Thirumalaisamy.
© 2026.
24 pages.
|
|
S. Ida Evangeline.
© 2026.
20 pages.
|
|
Ramya Raghavan, Srusti Shankar Moger, SaiMahima Umesh, G N Bhuvana.
© 2026.
36 pages.
|
|
Tiago Manuel Horta Reis da Silva.
© 2026.
32 pages.
|
|
Tiago Manuel Horta Reis da Silva.
© 2026.
32 pages.
|
|
|